| SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract YJ Hou, K Okuda, CE Edwards, DR Martinez, T Asakura, KH Dinnon, ... Cell 182 (2), 429-446. e14, 2020 | 1578 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 804 | 2021 |
| Human lung stem cell-based alveolospheres provide insights into SARS-CoV-2-mediated interferon responses and pneumocyte dysfunction H Katsura, V Sontake, A Tata, Y Kobayashi, CE Edwards, BE Heaton, ... Cell stem cell 27 (6), 890-904. e8, 2020 | 359 | 2020 |
| Secretory cells dominate airway CFTR expression and function in human airway superficial epithelia K Okuda, H Dang, Y Kobayashi, G Carraro, S Nakano, G Chen, T Kato, ... American journal of respiratory and critical care medicine 203 (10), 1275-1289, 2021 | 160 | 2021 |
| SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice KH Dinnon III, SR Leist, K Okuda, H Dang, EJ Fritch, KL Gully, ... Science translational medicine 14 (664), eabo5070, 2022 | 83 | 2022 |
| SARS-CoV-2 infection of airway cells causes intense viral and cell shedding, two spreading mechanisms affected by IL-13 CB Morrison, CE Edwards, KM Shaffer, KC Araba, JA Wykoff, DR Williams, ... Proceedings of the National Academy of Sciences 119 (16), e2119680119, 2022 | 79 | 2022 |
| DOCK2 is involved in the host genetics and biology of severe COVID-19 H Namkoong, R Edahiro, T Takano, H Nishihara, Y Shirai, K Sonehara, ... Nature 609 (7928), 754-760, 2022 | 65 | 2022 |
| The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases K Yagi, M Ishii, H Namkoong, T Asami, O Iketani, T Asakura, S Suzuki, ... BMC infectious diseases 17, 1-9, 2017 | 61 | 2017 |
| Prognostic values of the Berlin definition criteria, blood lactate level, and fibroproliferative changes on high-resolution computed tomography in ARDS patients T Kamo, S Tasaka, T Suzuki, T Asakura, S Suzuki, K Yagi, H Namkoong, ... BMC pulmonary medicine 19, 1-9, 2019 | 52 | 2019 |
| Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae T Asakura, M Ikeda, A Nakamura, S Kodera International Journal of Infectious Diseases 29, 91-95, 2014 | 49 | 2014 |
| Health-related quality of life is inversely correlated with C-reactive protein and age in Mycobacterium avium complex lung disease: a cross-sectional analysis of 235 … T Asakura, Y Funatsu, M Ishii, H Namkoong, K Yagi, S Suzuki, T Asami, ... Respiratory Research 16, 1-9, 2015 | 47 | 2015 |
| Prevalence and mechanisms of mucus accumulation in COVID-19 lung disease T Kato, T Asakura, CE Edwards, H Dang, Y Mikami, K Okuda, G Chen, ... American journal of respiratory and critical care medicine 206 (11), 1336-1352, 2022 | 46 | 2022 |
| Clarithromycin expands CD11b+Gr-1+ cells via the STAT3/Bv8 axis to ameliorate lethal endotoxic shock and post-influenza bacterial pneumonia H Namkoong, M Ishii, H Fujii, K Yagi, T Asami, T Asakura, S Suzuki, ... PLoS pathogens 14 (4), e1006955, 2018 | 44 | 2018 |
| A second update on mapping the human genetic architecture of COVID-19 M Kanai, SJ Andrews, M Cordioli, C Stevens, BM Neale, M Daly, A Ganna, ... Nature 621 (7977), E7-E26, 2023 | 42 | 2023 |
| Acute onset olfactory/taste disorders are associated with a high viral burden in mild or asymptomatic SARS-CoV-2 infections K Nakagawara, K Masaki, Y Uwamino, H Kabata, S Uchida, S Uno, ... International Journal of Infectious Diseases 99, 19-22, 2020 | 42 | 2020 |
| Anti-inflammatory roles of mesenchymal stromal cells during acute Streptococcus pneumoniae pulmonary infection in mice T Asami, M Ishii, H Namkoong, K Yagi, S Tasaka, T Asakura, S Suzuki, ... Cytotherapy 20 (3), 302-313, 2018 | 42 | 2018 |
| Long-term outcome of pulmonary resection for nontuberculous mycobacterial pulmonary disease T Asakura, N Hayakawa, N Hasegawa, H Namkoong, K Takeuchi, ... Clinical Infectious Diseases 65 (2), 244-251, 2017 | 42 | 2017 |
| Natural history of Mycobacterium fortuitum pulmonary infection presenting with migratory infiltrates: a case report with microbiological analysis S Okamori, T Asakura, T Nishimura, E Tamizu, M Ishii, M Yoshida, ... BMC infectious diseases 18, 1-6, 2018 | 40 | 2018 |
| An epithelial-immune circuit amplifies inflammasome and IL-6 responses to SARS-CoV-2 KC Barnett, Y Xie, T Asakura, D Song, K Liang, SA Taft-Benz, H Guo, ... Cell Host & Microbe 31 (2), 243-259. e6, 2023 | 37 | 2023 |
| Characteristics of hospitalized patients with COVID-19 during the first to fifth waves of infection: a report from the Japan COVID-19 Task Force H Lee, S Chubachi, H Namkoong, T Asakura, H Tanaka, S Otake, ... BMC infectious diseases 22 (1), 935, 2022 | 35 | 2022 |
Ho NamkoongKeio University School of Medicine在 keio.jp 的电子邮件经过验证